MIDEAS and breast cancer: To further validate the decrease in MIDEAS-AS1 in breast cancer, we examined the expression of MIDEAS-AS1 using qRT-PCR in breast cancer tissues and their adjacent normal breast tissues, as well as, TNBC and non-TNBC tissues.